We focus on mechanisms of relapse after CAR-T therapy. Our goal is to design innovative combined IMT for relapsing/refractory Leukemia & Lymphoma. @MarcoRuella

ID: 1210594006641651715

linkhttps://www.med.upenn.edu/cci/ruellalab/ calendar_today27-12-2019 16:12:27